COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,763 Articles (22,502 medRxiv, 8,261 bioRxiv)

Most recent first Previous |  Page 2236: Articles 22351-22360  | Next

Equivalent SARS-CoV-2 viral loads between nasopharyngeal swab and saliva in symptomatic patients
Yokota, I., Hattori, T., Shane, P. Y., Konno, S., Nagasaka, A., Takeyabu, K., Fujisawa, S., Nishida, M., Teshima, T.
10.1101/2020.09.01.20186254 — Posted: 2020-09-03
A hospital-wide response to multiple outbreaks of COVID-19 in Health Care WorkersLessons learned from the field
Buising, K., Williamson, D., Cowie, B., MacLachlan, J., Orr, L., MacIsaac, C., Williams, E., Bond, K., Muhi, S., McCarthy, J., Maier, A., Irving, L., Heinjus, D., Kelly, C., Marshall, C.
10.1101/2020.09.02.20186452 — Posted: 2020-09-03
Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.
Annen, K., Morrison, T. E., DomBourian, M. G., McCarthy, M. K., Huey, L., Merkel, P. A., Andersen, G., Schwartz, E., Knight, V.
10.1101/2020.09.01.20185942 — Posted: 2020-09-03
Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia SARS Antigen point-of-care test.
Young, S., Taylor, S., Cammarata, C., Roger-Dalbert, C., Montano, A., Griego-Fullbright, C., Burgard, C., Fernandez, C., Eckert, K., Andrews, J. C., Ren, H., Allen, J., Ackerman, R., Gary, D., Cooper, C.
10.1101/2020.09.01.20185777 — Posted: 2020-09-03
Development and validation of a multiplex bead based assay for the detection of antibodies directed against SARS-CoV-2 proteins
Bray, R. A., Lee, J.-H., Brescia, P., Kumar, D., Nong, T., Shih, R., Woodle, E. S., Maltzman, J. S., Gebel, H. M.
10.1101/2020.09.02.20185199 — Posted: 2020-09-03
A Mental Health Paradox: Mental health was both a motivator and barrier to physical activity during the COVID-19 pandemic
Marashi, M. Y., Nicholson, E., Ogrodnik, M., Fenesi, B., Heisz, J. J.
10.1101/2020.09.03.280719 — Posted: 2020-09-03
The discovery of gene mutations making SARS-CoV-2 well adapted for humans: host-genome similarity analysis of 2594 genomes from China, the USA and Europe
Sun, W.
10.1101/2020.09.03.280727 — Posted: 2020-09-03
Phylo-geo-network and haplogroup analysis of 611 novel Coronavirus (nCov-2019) genomes from India
Laskar, R., Ali, S.
10.1101/2020.09.03.281774 — Posted: 2020-09-03
A Single Dose of Self-Transcribing and Replicating RNA Based SARS-CoV-2 Vaccine Produces Protective Adaptive Immunity In Mice
de Alwis, R. M., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Matsuda, D., Allen, E., Hartman, P., Park, J., Alayyoubi, M., Bhaskaran, H., Dukanovic, A., Bao, B., Clemente, B., Vega, J., Roberts, S., Gonzalez, J. A., Sablad, M., Yelin, R., Taylor, W., Tachikawa, K., Parker, S., Karmali, P., Davis, J., Sullivan, S. M., Hughes, S. G., Chivukula, P., Ooi, E. E.
10.1101/2020.09.03.280446 — Posted: 2020-09-03 Discussion: Onsite
Boosting the analysis of protein interfaces with Multiple Interface String Alignment: illustration on the spikes of coronaviruses
Bereux, S., Delmas, B., Cazals, F.
10.1101/2020.09.03.281600 — Posted: 2020-09-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).